GB9911824D0 - New vaccine formulations - Google Patents

New vaccine formulations

Info

Publication number
GB9911824D0
GB9911824D0 GBGB9911824.2A GB9911824A GB9911824D0 GB 9911824 D0 GB9911824 D0 GB 9911824D0 GB 9911824 A GB9911824 A GB 9911824A GB 9911824 D0 GB9911824 D0 GB 9911824D0
Authority
GB
United Kingdom
Prior art keywords
vaccine formulations
new vaccine
new
formulations
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9911824.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyvax Ltd
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Priority to GBGB9911824.2A priority Critical patent/GB9911824D0/en
Publication of GB9911824D0 publication Critical patent/GB9911824D0/en
Priority to ES00931400T priority patent/ES2215662T3/en
Priority to JP2000619457A priority patent/JP2003500366A/en
Priority to AU49356/00A priority patent/AU4935600A/en
Priority to KR1020017014806A priority patent/KR20020027318A/en
Priority to EP00931400A priority patent/EP1178822B1/en
Priority to PCT/GB2000/001921 priority patent/WO2000071156A2/en
Priority to PCT/GB2000/001918 priority patent/WO2000071155A2/en
Priority to DE60008368T priority patent/DE60008368T2/en
Priority to AT00931400T priority patent/ATE259655T1/en
Priority to AU49357/00A priority patent/AU4935700A/en
Priority to CA002374294A priority patent/CA2374294A1/en
Ceased legal-status Critical Current

Links

GBGB9911824.2A 1999-05-21 1999-05-21 New vaccine formulations Ceased GB9911824D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB9911824.2A GB9911824D0 (en) 1999-05-21 1999-05-21 New vaccine formulations
CA002374294A CA2374294A1 (en) 1999-05-21 2000-05-19 New vaccine formulations - 2
KR1020017014806A KR20020027318A (en) 1999-05-21 2000-05-19 New vaccine formulations-2
JP2000619457A JP2003500366A (en) 1999-05-21 2000-05-19 New vaccine preparation 2
AU49356/00A AU4935600A (en) 1999-05-21 2000-05-19 New vaccine formulations - 2
ES00931400T ES2215662T3 (en) 1999-05-21 2000-05-19 VACCINE OF WHOLE CELLS FOR CANCER CONTAINING MALIGNAL AND NON-MALIGNED CELL CELLS.
EP00931400A EP1178822B1 (en) 1999-05-21 2000-05-19 Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells
PCT/GB2000/001921 WO2000071156A2 (en) 1999-05-21 2000-05-19 New vaccine formulations-3
PCT/GB2000/001918 WO2000071155A2 (en) 1999-05-21 2000-05-19 New vaccine formulations - 2
DE60008368T DE60008368T2 (en) 1999-05-21 2000-05-19 WHOLE CELLS OF CANCER VACCINE, CONTAINING CO-CULTIVATED MALIGNE AND NON-MALIGNE CELLS
AT00931400T ATE259655T1 (en) 1999-05-21 2000-05-19 WHOLE CELL CANCER VACCINE CONTAINING CO-CULTURED MALIGINAL AND NON-MALIGINAL CELLS
AU49357/00A AU4935700A (en) 1999-05-21 2000-05-19 New vaccine formulations-3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9911824.2A GB9911824D0 (en) 1999-05-21 1999-05-21 New vaccine formulations

Publications (1)

Publication Number Publication Date
GB9911824D0 true GB9911824D0 (en) 1999-07-21

Family

ID=10853880

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9911824.2A Ceased GB9911824D0 (en) 1999-05-21 1999-05-21 New vaccine formulations

Country Status (1)

Country Link
GB (1) GB9911824D0 (en)

Similar Documents

Publication Publication Date Title
PL392363A1 (en) Vaccine formulation
IL145045A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
GB9910812D0 (en) Vaccine composition
GB9915204D0 (en) Vaccine
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
GB9911823D0 (en) New vaccine formulations
GB9911825D0 (en) New vaccine formulations
GB9911824D0 (en) New vaccine formulations
GB9909072D0 (en) Vaccine
GB0008029D0 (en) New vaccine formulations
GB9925618D0 (en) Vaccine
GB9918647D0 (en) Vaccine
GB9925619D0 (en) Vaccine
GB9922703D0 (en) Vaccine
GB9922701D0 (en) Vaccine
GB9922700D0 (en) Vaccine
GB9904405D0 (en) Vaccine
GB9915106D0 (en) Vaccine
GB9917144D0 (en) Vaccine
GB9916677D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9919260D0 (en) Vaccine
GB9905511D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)